CRISPR Panel Discussion on June 24, 2024 focused on the ethics surrounding CRISPR technology and its potential uses in clinical and research practices. Panelists included Christopher McKinney, MD, CU-SOM Hematology/Oncology and Sickle Cell Disease specialist at Children's Hospital Colorado, Curtis R. Coughlin II, PhD, MS, MBE, CU-SOM Pediatrics and Genetic Counselor, and Lindsay Brubaker, MD, CU-SOM, Gynecologic Oncology, and moderated by Arjun Singh, MS1, CU School of Medicine, Class of 2027. Sponsored by the Center for Bioethics and Humanities Student Group.